Tacrolimus in ulcerative colitis – extended three center experience
KJ Schmidt(Universitäres Kinderwunschzentrum Lübeck), K Herrlinger(Robert Bosch Hospital), Klaus Fellermann(Apple (Israel)), EF Stange(Robert Bosch Hospital), DN Barthel(Robert Bosch Hospital), Hülya Koç, Jürgen Büning(University Hospital Schleswig-Holstein), Danièl Thomas(Unknown), H. Lehnert(University Hospital Schleswig-Holstein), Jörg Emmrich(University of Rostock)
Cited by 0
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
|Nature Medicine|2015|579
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566